Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | FABP7 | O15540 | 2/20 | 0.43 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.43 |
| ▸ | CASP3 | P42574 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MDM4 | O15151 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30522780 | 1.00 | EPHX2 (0.56) | EPHX2KMT2APOLBFABP7FABP5 | |
| SCHEMBL26628373 | 0.93 | EPHX2 (0.52) | EPHX2KMT2APOLBFABP7FABP5 | |
| SCHEMBL29547060 | 0.93 | EPHX2 (0.52) | EPHX2KMT2APOLBFABP7FABP5 | |
| SCHEMBL29546978 | 0.93 | EPHX2 (0.52) | EPHX2KMT2APOLBFABP7FABP5 | |
| SCHEMBL3209189 | 0.90 | EPHX2 (0.54) | EPHX2KMT2AFABP7FABP5CASP3 | |
| SCHEMBL3214751 | 0.90 | EPHX2 (0.57) | EPHX2KMT2AFABP7FABP5CASP3 | |
| SCHEMBL3209502 | 0.90 | EPHX2 (0.57) | EPHX2KMT2AFABP7FABP5CASP3 | |
| SCHEMBL31423769 | 0.89 | EPHX2 (0.53) | EPHX2KMT2AFABP7FABP5CASP3 | |
| SCHEMBL29547309 | 0.89 | EPHX2 (0.53) | EPHX2KMT2AFABP7FABP5CASP3 | |
| SCHEMBL14701886 | 0.89 | EPHX2 (0.53) | EPHX2KMT2AFABP7FABP5CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119173278-A | Antibody-conjugated drugs and uses thereof | 维硕公司 | 2024-12-20 | — | — | CN | disclosed |
| WO-2023173026-A1 | ANTIBODY-DRUG CONJUGATES AND USES THEREOF | SORRENTO THERAPEUTICS, INC. (US) | 2023-09-14 | — | — | WO | disclosed |